Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ALUMIS INC. | 5,896,995 | 5,896,995 | 0 | 129,911 | 165,941 | 45.81% | +36,031 |
| Pharvaris N.V. COM | 194,125 | 664,142 | +470,017 | 5,484 | 22,966 | 6.34% | +17,482 |
| Odyssey Therapeutics, Inc. | 0 | 713,105 | +713,105 | 0 | 13,342 | 3.68% | +13,342 |
| Hims & Hers Health, Inc.(HIMS) | 738,151 | 738,151 | 0 | 15,324 | 25,592 | 7.07% | +10,268 |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,079,050 | +75,000 | 67,954 | 76,667 | 21.17% | +8,712 |
| Disc Medicine, Inc.(IRON) | 374,069 | 374,069 | 0 | 23,918 | 27,359 | 7.55% | +3,441 |
| Eikon Therapeutics, Inc.(EIKN) | 1,318,983 | 1,318,983 | 0 | 13,955 | 17,213 | 4.75% | +3,258 |
| Nurix Therapeutics, Inc.(NRIX) | 265,000 | 265,000 | 0 | 4,108 | 6,429 | 1.77% | +2,321 |
| Maze Therapeutics, Inc.(MAZE) | 25,905 | 0 | -25,905 | 773 | 0 | — | -773 |
| Lyell Immunopharma, Inc.(LYEL) | 477,078 | 476,386 | -692 | 9,570 | 6,693 | 1.85% | -2,877 |